AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- The 2022-2023 nationwide shortage of stimulant medications for attention deficit-hyperactivity disorder (ADHD) may have been driven by international supply chain disruptions rather than overprescribing, an economic evaluation...
Source
MedPage Today
Opens original article in a new tab
RFK Jr. and a top adviser are continuing the search for a new CDC director past a statutory deadline.
(MedPage Today) -- The FDA approved relacorilant (Lifyorli) in combination with nab-paclitaxel (Abraxane) for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. The combination of...
(MedPage Today) -- Vasectomy remains a safe and effective permanent contraceptive option for men and has no established links to serious health conditions, including prostate cancer, according to an updated guideline from the American Urological...
(MedPage Today) -- An individualized dosing regimen of the inhaled psychedelic mebufotenin (GH001) led to significant improvements in depression symptoms in patients with treatment-resistant depression, a randomized placebo-controlled trial showed...